-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, MlDAcCepNuKTj4X6oXj+uT/KOT+wsYcdnoHgo2lLkY6Ktw0uPY/2YCHhBMkomIGq 73JQfGoNyojCuhNmhvCpzg== 0000071241-06-000008.txt : 20060608 0000071241-06-000008.hdr.sgml : 20060608 20060608145420 ACCESSION NUMBER: 0000071241-06-000008 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20060608 ITEM INFORMATION: Entry into a Material Definitive Agreement ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20060608 DATE AS OF CHANGE: 20060608 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NEW BRUNSWICK SCIENTIFIC CO INC CENTRAL INDEX KEY: 0000071241 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY APPARATUS & FURNITURE [3821] IRS NUMBER: 221630072 STATE OF INCORPORATION: NJ FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-06994 FILM NUMBER: 06893854 BUSINESS ADDRESS: STREET 1: 44 TALMADGE RD STREET 2: PO BOX 4005 CITY: EDISON STATE: NJ ZIP: 08818-4005 BUSINESS PHONE: 9082871200 MAIL ADDRESS: STREET 1: 44 TALMADGE ROAD STREET 2: PO BOX 4005 CITY: EDISON STATE: NJ ZIP: 08818-4005 8-K 1 form8ktbocchinoterm.txt FORM 8K T.BOCCHINO TERM AGREEMENT UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): JUNE 8, 2006 NEW BRUNSWICK SCIENTIFIC CO., INC. ---------------------------------- (Exact name of registrant as specified in its charter) NEW JERSEY 0-6994 22-1630072 ---------- ------ ---------- (State or other jurisdiction (Commission (IRS Employer of incorporation) File Number) Identification No.) P.O. BOX 4005 44 TALMADGE ROAD EDISON, NEW JERSEY 08818-4005 ------------------ ---------- (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code: (732) 287-1200 N/A (Former name or former address, if changed since last report.) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below): [ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) [ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) [ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) [ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) ITEM 1.01 ENTRY INTO A MATERIAL DEFINITIVE AGREEMENT. On June 7, 2006, New Brunswick Scientific Co., Inc. ("Company") entered into an Involuntary Termination Agreement with Thomas Bocchino, Vice President, Finance and Chief Financial Officer. Under the terms of the agreement, should Mr. Bocchino's employment with the Company be involuntarily terminated for any reason after a Change in Control, the Company agrees to pay Mr. Bocchino 200% of his current base salary at the time of such termination. ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS. (D) EXHIBITS Exhibit Number Description of the Exhibit 10.38 Involuntary Termination Agreement with Thomas Bocchino. - ------ ------------------------------------------------------------ Signatures Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. New Brunswick Scientific Co., Inc. Date: June 8, 2006 By: /s/ Thomas Bocchino -------------------- Thomas Bocchino Vice President, Finance and Chief Financial Officer EX-10.38 2 exh1038involtermagree.txt EXHIBIT 10.38 INVOL TERM AGREE Exhibit 10.38 [Letterhead of New Brunswick Scientific Co., Inc.] FEBRUARY 23, 2006 Mr. Thomas Bocchino 13 Cooper Hawk Drive Manalapan, NJ 07726 Dear Mr. Bocchino: In recognition of your services, New Brunswick Scientific Co., Inc. (the "Company") shall, in the event that your employment with the Company is involuntarily terminated for any reason after the occurrence of a Change in Control (as defined below), pay to you an amount equal to 200% of your current annual base salary at the time of such termination. The payment will be made in a single sum within 30 days of your termination of employment. For the purposes of this agreement "Change of Control" generally is defined to take place when disclosure of such a change would be required by rule(s) promulgated by the Securities and Exchange Commission or when either (i) a person (other than a current officer or director nominated, selected or elected by the board) acquires beneficial ownership (as defined in SEC Rule 13d-3) of 25% or more of the combined voting power of the Company's voting securities, (ii) less than a majority of the directors are persons who were either nominated or selected by the current board, (iii) a merger tender offer or sale or exchange of securities involving the Company occurs which results in ownership of more than 50% of the Company's voting stock by a holder or holders not currently owning more than 10% of the outstanding shares of stock of the Company, or (iv) a plan of liquidation or sale of substantially all the assets of the Company occurs. Following a Change in Control, in addition to actual termination of your employment by the Company, you will be considered to have been involuntarily terminated if you resign after any of the following occurs: a material reduction in your responsibilities or authority which is expected to last or in fact continues for more than one month; a reassignment to another geographic location more than 50 miles from 44 Talmadge Road, Edison, New Jersey; a reduction of at least 5% in your compensation; abusive or demeaning conduct toward you that amounts to a constructive discharge under the common law of the State of New Jersey; or failure by a successor employer following a sale, merger, exchange or other disposition of the Company, or any subsidiary, facility, or operation at which you are employed to assume the obligations of the Company under this Agreement. Nothing contained herein shall be construed as conferring upon you the right to continue in the employ of the Company as an executive or in any other capacity. MR. THOMAS BOCCHINO PAGE 2 Any severance pay benefits payable under this letter shall not be deemed salary or other compensation to you for the purpose of computing benefits to which you may be entitled under any pension plan or other arrangement of the Company for the benefit of its employees. You shall be responsible for payment of any tax liability which results from payment to you of any amount under this letter. Any payment(s) shall be subject to Federal, State and local withholding rules in effect at the time a payment is made. The parties hereto agree that this Agreement shall supercede any and all other agreements between the parties relating to severance pay. Sincerely, NEW BRUNSWICK SCIENTIFIC CO., INC. ATTEST: David Freedman Chief Executive Officer ADELE LAVENDER Secretary Acknowledged and Accepted as of the 7th Day of June 2006 Thomas Bocchino -----END PRIVACY-ENHANCED MESSAGE-----